L. Ben-Porat
Annals of Surgery · 2002–2004
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Who trusts L. Ben-Porat overall
Papers from L. Ben-Porat's perspective
Ordered by how strongly the researchers L. Ben-Porat trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonparametric Estimation from Incomplete Observations
- A 20-year perspective on the International Fanconi Anemia Registry (IFAR). (Blood)
- The Statistical Analysis of Failure Time Data (Technometrics)
- Quality of Complication Reporting in the Surgical Literature (Annals of Surgery)
- Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. (Journal of the American College of Surgeons)
- Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma (Annals of Surgery)
- Categorical Data Analysis
- FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. (The Oncologist)
- ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. (Journal of Clinical Oncology)
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
Their papers
- A note on competing risks in survival data analysis (2004) — 730 citations
- Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. (2004) — 753 citations
- Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases (2003) — 598 citations
- Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade (2002) — 1,673 citations